Clinical Trial Update: CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing CS02 to placebo with metformin in type 2 diabetes patients with inadequate glycemic control has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CS02

Snippet

Sponsor: Center Laboratories, Inc. | Conditions: T2DM With Inadequate Glycemic Control | Phase 2 | Status: COMPLETED